ENHANCEMENT OF REDIRECTED TARGET-CELL LYSIS BY CYTOTOXIC LYMPHOCYTES-T IN THE PRESENCE OF CYTOCHALASIN-B

被引:3
作者
KOLBER, MA [1 ]
机构
[1] UNIV MIAMI,SCH MED,DEPT MICROBIOL & IMMUNOL,MIAMI,FL 33101
关键词
D O I
10.1016/0008-8749(91)90181-A
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The cytochalasins are known secretogogues. Their function as such is examined in light of the granule exocytosis model for lymphocyte-mediated cytotoxicity. Cytochalasin B is found to enhance target cell lysis by cytotoxic T lymphocytes when antibody-coated polystyrene beads are used to bridge the cells. The pattern of lysis is found to be biphasic in its dependence on cytochalasin B. Secretion of the enzyme BLT-esterase from the effector cells parallels the cytochalasin concentration-dependent pattern of lysis. Cytochalasin D is also able to enhance lysis but at concentrations less than Cytochalasin B. Cytochalasin B does not inhibit binding of beads to the effector cell. This is shown by the ability of fluorescent beads coated with antibody to bind with an appropriate specificity to cells. These studies indicate that cytochalasin B is not strictly inhibitory for the induction of target cell lysis but can enhance lymphocyte-mediated lysis at low drug concentrations. These results are compatible with the interpretation that target cell lysis is mediated through a secretion process from cytotoxic T lymphocytes. © 1991.
引用
收藏
页码:84 / 94
页数:11
相关论文
共 16 条
[1]  
BRUNNER KT, 1968, IMMUNOLOGY, V14, P181
[2]  
BUBBERS JE, 1975, J IMMUNOL, V115, P145
[3]   EFFECTS OF CYTOCHALASINS ON MAMMALIAN CELLS [J].
CARTER, SB .
NATURE, 1967, 213 (5073) :261-&
[4]   T-LYMPHOCYTE AGGREGATION WITH IMMOBILIZED ANTI-TCR-ANTIBODIES IS DEPENDENT UPON ENERGY AND MICROFILAMENT ASSEMBLY [J].
DEBELL, KE ;
TAPLITS, MS ;
HOFFMAN, T ;
BONVINI, E .
CELLULAR IMMUNOLOGY, 1990, 127 (01) :159-171
[5]  
GATELY MK, 1980, J IMMUNOL, V125, P783
[6]  
GREEN GDJ, 1979, ANAL BIOCHEM, V93, P223, DOI 10.1016/S0003-2697(79)80141-4
[7]  
HENKART P, 1988, PROG ALLERGY, V40, P82
[8]  
HENKART PA, 1985, ANNU REV IMMUNOL, V3, P29
[9]  
HONEYCUTT PJ, 1986, J BIOL CHEM, V261, P5900
[10]  
KOLBER MA, 1989, J IMMUNOL, V143, P1461